Lexeo Therapeutics Inc（LXEO）價格預測LXEOLexeo Therapeutics Inc

Alphio's LXEO stock price prediction model matches the current Lexeo Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.22 (-0.29%). The 1-week path is $3.32 (+2.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Lexeo Therapeutics Inc is currently not a strong buy. The stock is priced at $3.06, significantly below its 52-week high of $10.99, indicating a potential for recovery but also substantial risk. The RSI is at 55.25, suggesting that the stock is neither overbought nor oversold, which may indicate a stable trend. However, the forward P/E ratio is 5.66, which is low, but the company has been consistently reporting negative net income, with a net loss of $25.9 million in Q4 2024 and a gross profit of $0 in that same quarter. The recent insider selling has increased by 271.82%, which raises concerns about insider confidence. The main risk is the ongoing losses, as evidenced by a projected EPS of -0.33 for the next earnings report on November 4, 2026.

Lexeo Therapeutics Inc (LXEO) last closed at $3.23, gaining +3.86%. These facts feed the 1-day and 1-week LXEO price prediction above.